Myeloid Cell-Specific Deletion of mTOR Suppresses Psoriasis-Like Skin Inflammation in C57BL/6 Mice
April 2023
in “
Journal of Investigative Dermatology
”
TLDR Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.
This study explores the role of mTOR signaling in myeloid lineage cells in the development of psoriasis, an autoimmune skin disorder. Using a genetic mouse model with myeloid-specific deletion of mTOR, researchers found that these mice exhibited significantly less severe psoriasis-like skin inflammation compared to control mice. The mTOR-deficient mice showed reduced psoriasiform skin lesions, lower PASI scores, and decreased levels of immune cell infiltration, including helper T-lymphocytes, dendritic cells, and macrophages. These findings suggest that targeting mTOR in myeloid cells could be a potential therapeutic strategy for alleviating psoriasis.